| dc.contributor.author | Kanishk, Dang | |
| dc.date.accessioned | 2020-11-22T16:18:11Z | |
| dc.date.available | 2020-11-22T16:18:11Z | |
| dc.date.issued | 2020-10 | |
| dc.identifier.uri | https://stiinta.usmf.md/ro/manifestari-stiintifice/zilele-universitatii | |
| dc.identifier.uri | https://repository.usmf.md/handle/20.500.12710/13154 | |
| dc.description | Congresul consacrat aniversării a 75-a de la fondarea Universității de Stat de Medicină și Farmacie „Nicolae Testemițanu” din Republica Moldova, Ziua internațională a științei pentru pace și dezvoltare | en_US |
| dc.description.abstract | Introduction: • SARS-CoV-2 is a declared pandemic and health threat. • Previously identified SARS-CoV and MERS-CoV from the same Betacoronavirus genus had neurological implications. Purpose: To emphasize relationship between neurological comorbidities and SARS-CoV-2 and management. Material and methods: A systematic review of PubMed and ResearchGate articles using the mentioned keywords. Results: One-tenth of patients with existing neurological comorbidities develop SARS-CoV-2. Conclusions: • Neurological comorbidities increased susceptibility and presented in SARS-CoV-2. • Differentiate existing comorbidities and SARS-CoV-2 to avoid misdiagnosis. • Develop individualized plan to maintain treatment and prevent exacerbation. | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | Universitatea de Stat de Medicină şi Farmacie "Nicolae Testemiţanu" | en_US |
| dc.subject | SARS-CoV-2 | en_US |
| dc.subject | coronavirus | en_US |
| dc.subject | neurology | en_US |
| dc.subject | comorbidities | en_US |
| dc.subject | 2019-nCoV | en_US |
| dc.title | Neurological comorbidities in patients with severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) | en_US |
| dc.type | Working Paper | en_US |